Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
April 23, 2014, 09:22:28 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 621104
  • Total Topics: 46783
  • Online Today: 211
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: New studies detail how HIV affects immune system, claim drug exists to block vir  (Read 862 times)

0 Members and 1 Guest are viewing this topic.

Offline GoForIt

  • Member
  • Posts: 87
http://www.washingtonpost.com/national/health-science/new-studies-detail-how-hiv-affects-immune-system-claim-drug-exists-to-block-virus/2013/12/19/1697afea-68c9-11e3-a0b9-249bbb34602c_story.html

In a last-ditch effort to rid the body of HIV, droves of white bloods cells self-destruct in an explosive mass suicide that drives the progression toward AIDS, a pair of new studies has found.

These fiery deaths attract more unsuspecting cells to come over and help, initiating a domino effect of immune system destruction. The discovery of these mechanisms of cell death has solved a decades-long mystery that has plagued HIV researchers since the emergence of the disease. And researchers claim an existing drug may be able to halt this suicide cascade in its tracks.

The study in Nature identifies the chain reaction and corresponding enzymes involved. The other from Science pinpoints a protein within the white blood cell that sniffs out the viral DNA and tells the cell to pull the trigger on itself. Both were published online Thursday.

“For literally thirty years, we thought it was directly the virus killing the cell,” said immunologist Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, who was not involved in the studies. “This wasn’t a particularly satisfying explanation since many, many more cells die than were infected.”

Both findings come from the laboratory of immunologist Warner Greene of the Gladstone Institutes, a biomedical research nonprofit in California.

HIV most often targets a type of white blood cell, called CD4 T-cell. The virus latches on to some of these cells and inserts its own genetic material inside. Some of these T-cells become virus-replicating units, but other cells resist and become bystanders called resting cells.

Scientists have speculated that the virus-producing infected cells become so full of the virus they were producing that they die. Or they realize something was very wrong, and perform a clean programmed cell death called apoptosis.

The deaths of these CD4 T-cells are offset by the body producing more of them in response. But after a while, the body can’t keep up, and the T-cell count drops leading to the onset of AIDS. Then, diseases that used to be easy to fend off can take over.

“It’s really a race between production and destruction,” said Fauci.

For 30 years, scientists have thought that AIDS was brought on solely by the virus-producing infected cells, rather than the resting cells. But there weren’t enough of these infected cells to explain the huge swaths of T-cells being wiped out in patients developing AIDS.

Greene and his colleagues discovered that 95 percent of the dying T-cells were resting cells. These cells have the virus DNA in them, but unlike the cells that become virus-replicating units, the resting cells initiate a self-destruct mechanism that is downright gruesome, called pyroptosis. It causes cell swelling, membrane rupture, and leaky insides.

“It is much more a cellular suicide than a viral murder,” said Greene. “The cells are committing suicide in a vain attempt to kill the virus.”

Because of its explosive and messy nature, pyroptosis is a good way of signalling to the troops to help clean up. But inflammation of these cells during death causes the new cells to fall to the same grim fate.

“This process just becomes a gristmill for chewing up CD4 cells,” Greene said.

His team took four years to gather all the results. First, they inserted a fluorescent dye into the virus so they could identify which cells harbored HIV-replicating units. Then they waited to see which cells died. To their shock, the vast majority of cell death was among the resting, non-virus-replicating cells.

From there, they wanted to find the molecule that was the pyroptosis instigator. The team analyzed the DNA of the resting CD4 T-cells using a technique called mass spectroscopy to find every protein that was bound to it. From the original laundry list of proteins, they picked the most likely candidates and progressively knocked out each one in newly made T-cells to tease out what each protein did. When they knocked out one in particular, IFI16, the cells no longer self-destructed.

“IFI16 is like the trigger, and the pyroptosis is like the gun,” he said. “IFI16 initiates the response.”

Greene and his colleagues also describe a drug – one already cleared for human use, originally developed to prevent seizures – that could potentially prevent pyroptosis. After IFI16 recognizes the virus DNA, it triggers a series of responses in the cell, including the work of an enzyme caspase-1 that mediates pyroptosis. The drug blocks that enzyme.

“They are actually on the shelf, waiting for a disease,” said Greene, who is trying to develop a clinical trial for use of the drug in HIV/AIDS patients. “We tested that drug in our tissue culture systems, and it works beautifully.”

It differs from the antiretrovirals currently used for HIV/AIDS in that it would target the host rather than the virus. However, Fauci doesn’t believe that it will be a replacement for antiretrovirals, but instead they could possibly be used together as a joint treatment.

Greene saw his first AIDS case in 1981 — the year the disease was identified — while working at the National Institutes of Health. At the time, he was conducting research on a different human retrovirus, but found himself fascinated by the ever-unfolding mysteries of HIV.

“Every step of the way in this field of work, I have been absolutely amazed,” he said. “Each lab meeting is thrilling.”
08/09/2013   Diagnosed WB positive
08/20/2013   CD4-506(28%)  VL-10,800
09/12/2013   CD4-391(28%)  VL-14,900
09/17/2013   Start ART (Truvada & Tivicay)
10/11/2013   CD4-377(26%)  VL-UD
12/20/2013   CD4-590(??%)  VL-UD
03/18/2014   CD4-660(29%)  VL-UD

Offline freewillie99

  • Member
  • Posts: 303
This seems like a pretty big deal.
Beware Romanians bearing strange gifts

Offline elf

  • Member
  • Posts: 583
Melatonin can inhibit caspase-1 too:  :)

Quote
Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.
http://www.ncbi.nlm.nih.gov/pubmed/23537713
Let's have a Kiki!

Offline tednlou2

  • Member
  • Posts: 4,613
This is very interesting.  It does beg the question how severe the virus would be, if our cells weren't "committing suicide" in an attempt to protect us. 

Offline Tadeys

  • Member
  • Posts: 159
This is very interesting.  It does beg the question how severe the virus would be, if our cells weren't "committing suicide" in an attempt to protect us. 


Good point. I believe one species of monkey with SIV does progress to AIDS, and another species does not. The species that does not progress does not have all this inflammation going on, and from what I remember, their body has learned to live with the virus...so I asume there isnt much harakiri going on.

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.